About Dr. Ankur BAHL
Dr. Ankur Bahl is a highly skilled cancer specialist who has more than 15+ years ofrich experience in this field. He is an alumni of Maulana Azad Medical CollegeDelhi from where he did his MBBS, followed by MD Medicine. He has done his DMMedical Oncology from the prestigious AIIMS New Delhi. He has also completeda course on Adverse Drug Reactions, Drug Interactions and Pharma covigilance at the University of Oxford UK. Dr. Bahl holds clinical expertise inImmunotherapy, targeted therapies in combination with Chemotherapy,Hormonal Therapy, Supportive and Palliative Care. He is the lead author of largest real world Indian data on targeted therapy(Cetuxmab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment,Human Pappiloma Virus trends in Indian Population etc. He is also the leadfounder of various innovative oncology educational platforms and networks(International and national) Evidence based debates in oncology, Live Oncology Tumour boards, Master Classes andworkshops in oncology Dr Bahl has joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and HaematologyOncology, Previously he was associated with prestigious organisation like Rajiv Gandhi Cancer Institute and ResearchCentre and Maulana Azad Medical College.
Hospital
Fortis Hospital
, Delhi NCR
Location
No
Special Interest
List Of Treatments
Metastatic Tumors Treatment
Chemotherapy
Radiotherapy
Adrenal Cancer Treatment
Anal Cancer Treatment
Bile Duct Cancer Treatment
Bladder Cancer Treatment
Bone Cancer Treatment
Breast Cancer-Surgical
Cancer in Children
Carcinoma of Unknown Primary (CUP) Treatment
Castleman Disease Treatment
Cervical Cancer Treatment
Endometrial Cancer Treatment
Esophagus Cancer Treatment
Ewing Family of Tumors Treatment
Eye Cancer Treatment
Gallbladder Cancer Treatment
Carcinoid Tumors Treatment
Gastrointestinal Stromal Tumor GIST Treatment
Gestational Trophoblastic Disease (GTD) Treatment
Hodgkin Disease Treatment
Kaposi Sarcoma Treatment
Kidney Cancer Treatment
Laryngeal and Hypopharyngeal Cancer Treatment
Acute Lymphocytic Leukemia - ALL in Adults
Leukemia - Acute Myeloid AML
Chronic Lymphocytic Leukemia - CLL
Chronic Myeloid Leukemia- CML
Chronic Myelomonocytic Leukemia - CMML
Leukemia in Children
Liver Cancer
Lung Cancer Treatment
Non-Small Cell Lung Cancer (NSCLC) Treatment
Small-cell Carcinoma Treatment
Lung Carcinoid Tumor Treatment
Skin Lymphoma Treatment
Malignant Mesothelioma Treatment
Multiple Myeloma Treatment
Nasal Cavity and Paranasal Sinus Cancer Treatment
Nasopharyngeal Cancer Treatment
Neuroblastoma
Non-Hodgkin Lymphoma (NHL) Treatment
Non-Hodgkin Lymphoma In Children
Oral Cavity and Oropharyngeal Cancer
Osteosarcoma (OS) Treatment
Ovarian Cancer Surgery
Pancreatic Cancer
Penile Cancer Treatment
Prostate Cancer-Surgical
Retinoblastoma (RB) Treatment
Rhabdomyosarcoma (RMS) Treatment
Salivary Gland Cancer
Soft Tissue Sarcoma Treatment
Skin Cancer
Basal Cell and Squamous Cell Carcinoma
Skin Cancer - Melanoma
Small Intestine Cancer Treatment
Stomach Cancer Treatment
Testicular Cancer Treatment
Thymoma and Thymic Carcinoma Treatment
Thyroid Cancer Treatment
Uterine Sarcoma
Vaginal Cancer Treatment
Vulvar Cancer Treatment
Waldenstrom Macroglobulinemia
Wilms Tumor (Nephroblastoma)
Breast Biopsy
Autologous Stem Cell Transplant for Lymphoma
Pediatric Bone Marrow Transplant
Oral Cancer - Surgical
Breast Cancer
Leukemia Treatment
Hairy Cell Leukemia - HCL
Fallopian Tube Cancer
Ovarian Germ Cell Tumor
Ovarian Primary Peritoneal Cancer
Medullary Carcinoma
Papillary Thyroid Cancer Treatment
Bone Marrow Cancer
Ovarian Sex Cord Stromal Tumor
Invasive Lobular Carcinoma
Colon Cancer Treatment
Cancer Treatment
Adenocarcinoma - Glandular Cancer Treatment
Immunotherapy